Recent studies have shown that depletion of Tregs in the TME by depleting anti-CD137 mAb decreased tumor growth, indicating that Tregs in the TME express CD137 to suppress antitumor hyperimmune responses (72, 130). This evidence concerns the gene TNFRSF9 and neoplasm.